| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Eiji Kirin. Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29209406. |
serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics. |
2020-10-01 |
2023-08-13 |
Not clear |
| Saeed Ahmed, Ali Mahmood Khan, Hema Madhuri Mekala, Hema Venigalla, Rizwan Ahmed, Amira Etman, Michael Esang, Mustafa Quresh. Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis. Heliyon. vol 3. issue 11. 2020-10-01. PMID:29264404. |
to assess the relative efficacies of clozapine plus electroconvulsive therapy (ect) compared against non-clozapine typical and atypical antipsychotics plus ect for the treatment of "treatment resistant schizophrenia" (trs). |
2020-10-01 |
2023-08-13 |
Not clear |
| Congjie Wang, Wenjie Shi, Chengbing Huang, Jiannan Zhu, Wenzhong Huang, Gang Che. The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29299043. |
the efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial. |
2020-10-01 |
2023-08-13 |
Not clear |
| Congjie Wang, Wenjie Shi, Chengbing Huang, Jiannan Zhu, Wenzhong Huang, Gang Che. The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial. Annals of general psychiatry. vol 16. 2020-10-01. PMID:29299043. |
this study attempted to understand whether there are any differences in efficacy, acceptability, and safety between the five atypical antipsychotics in patients with first-episode schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Kyle J Burghardt, Jacyln M Goodrich, Brittany N Lines, Vicki L Ellingro. The Influence of Metabolic Syndrome and Sex on the DNA Methylome in Schizophrenia. International journal of genomics. vol 2018. 2020-10-01. PMID:29850476. |
within this study, the dna methylome was profiled to identify altered methylation associated with metabolic syndrome in a schizophrenia population on atypical antipsychotics. |
2020-10-01 |
2023-08-13 |
Not clear |
| Zhi-Min Yu, Ying Zhao, Jin-Qiong Zhan, Tao Luo, Jian-Wen Xiong, Bin Yu, Bo Wei, Yuan-Jian Yan. Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia. Frontiers in psychiatry. vol 9. 2020-10-01. PMID:30687138. |
atypical antipsychotics can produce cognitive benefits in schizophrenia patients. |
2020-10-01 |
2023-08-13 |
Not clear |
| Zhi-Min Yu, Ying Zhao, Jin-Qiong Zhan, Tao Luo, Jian-Wen Xiong, Bin Yu, Bo Wei, Yuan-Jian Yan. Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia. Frontiers in psychiatry. vol 9. 2020-10-01. PMID:30687138. |
in this study, we conducted a prospective observation trial to explore whether plasma adma may serve as an indicator for evaluating cognitive improvements induced by atypical antipsychotics in patients with schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| V P Matei, T Purnichi, A Mihailescu, R Grigora. PROLACTIN LEVEL IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA TREATED FOR ONE YEAR WITH ATYPICAL ANTIPSYCHOTICS. Acta endocrinologica (Bucharest, Romania : 2005). vol 14. issue 4. 2020-10-01. PMID:31149301. |
prolactin level in patients with first episode schizophrenia treated for one year with atypical antipsychotics. |
2020-10-01 |
2023-08-13 |
Not clear |
| Carol Hensha. Reproductive risk: its role in maternal mental health. International psychiatry : bulletin of the Board of International Affairs of the Royal College of Psychiatrists. vol 7. issue 3. 2020-10-01. PMID:31508046. |
in high-income countries, the widespread use of atypical antipsychotics, most of which do not impair reproductive function, may lead to increased conception rates in women with schizophrenia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Yongmin Kim, Sheng-Min Wang, Kyung-Phil Kwak, Ho-Kyoung Yoon, Chi-Un Pae, Jung-Jin Kim, Won-Myong Bah. Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 14. issue 4. 2020-09-30. PMID:27776390. |
despite numerous atypical antipsychotics (aap) available, many patients with schizophrenia still experience lack of efficacy and persistent side-effects. |
2020-09-30 |
2023-08-13 |
Not clear |
| Yingchan Wang, Weijun Tang, Xiaoduo Fan, Jianye Zhang, Daoying Geng, Kaida Jiang, Dianming Zhu, Zhenhua Song, Zeping Xiao, Dengtang Li. Resting-state functional connectivity changes within the default mode network and the salience network after antipsychotic treatment in early-phase schizophrenia. Neuropsychiatric disease and treatment. vol 13. 2020-09-30. PMID:28223812. |
the purpose of this study was to examine the effects of atypical antipsychotics on dmn and sn and the relationship between these effects and symptom improvement in patients with schizophrenia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Haiyun Xu, Xiaoyin Zhuan. Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review. Neuropsychiatric disease and treatment. vol 15. 2020-09-30. PMID:31413575. |
the atypical antipsychotics (aaps) have been used as first-line drugs in psychiatric practice for a wide range of psychotic disorders, including schizophrenia and bipolar mania. |
2020-09-30 |
2023-08-13 |
Not clear |
| Raphael J. Leo, Paula Del Regn. Atypical Antipsychotic Use in the Treatment of Psychosis in Primary Care. Primary care companion to the Journal of clinical psychiatry. vol 2. issue 6. 2020-09-29. PMID:15014629. |
the atypical antipsychotics appear to be effective for schizophrenia as well as other psychotic disorders, including schizoaffective disorder and mood disorders with psychotic features. |
2020-09-29 |
2023-08-12 |
Not clear |
| Andy R Eugene, Jolanta Masia. Electrophysiological Neuroimaging using sLORETA Comparing 100 Schizophrenia Patients to 48 Patients with Major Depression. Brain : broad research in artificial intelligence and neuroscience. vol 5. issue 1-4. 2020-09-29. PMID:26609423. |
in this retrospective analysis of electroencephalograms were to identify a surrogate biomarker for the dopamine d2 receptors in the brain by comparing patients diagnosed with schizophrenia taking atypical antipsychotics to depressive patients medicated with selective serotonin reuptake inhibitors. |
2020-09-29 |
2023-08-13 |
Not clear |
| Beatriz Beretta Alves, Giovana de Padua Oliveira, Milton Gabriel Moreira Neto, Roberta Bonamim Fiorilli, Elizabeth do Espírito Santo Cestári. Use of atypical antipsychotics and risk of hypertension: A case report and review literature. SAGE open medical case reports. vol 7. 2020-09-29. PMID:31007920. |
atypical antipsychotics is being considered in the treatment of "negative" symptoms of psychoses, such as schizophrenia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Leslie Citrome, Joseph P McEvoy, Mark S Todtenkopf, David McDonnell, Peter J Weide. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatric disease and treatment. vol 15. 2020-09-29. PMID:31564881. |
despite the fact that olanzapine is associated with a known risk of metabolic side effects, including weight gain, many clinicians continue to prescribe olanzapine for the treatment of schizophrenia with the expectation of additional therapeutic antipsychotic efficacy relative to other first-line atypical antipsychotics. |
2020-09-29 |
2023-08-13 |
Not clear |
| Jonathan R Scarf. Cariprazine for Schizophrenia and Bipolar Disorder. Innovations in clinical neuroscience. vol 13. issue 9-10. 2020-09-28. PMID:27975000. |
although atypical antipsychotics reduce positive and negative symptoms of schizophrenia as well as manic or mixed episodes of bipolar disorder, they are associated with varying degrees of metabolic adverse effects. |
2020-09-28 |
2023-08-13 |
Not clear |
| I C Miron, F Popescu, V Enăchescu, O M Cristea, E C Stoicănescu, E Amzoiu, M Amzoiu, F D Popesc. Combination of Olanzapine Pamoate with Melatonin and Metformin: Quantitative Changes in Rat Adipose Tissue. Current health sciences journal. vol 45. issue 4. 2020-09-28. PMID:32110439. |
olanzapine is one of the atypical antipsychotics widely used in the treatment of schizophrenia and has been associated with metabolic changes as adverse effects, including hyperglycemia, dyslipidemia, and weight gain. |
2020-09-28 |
2023-08-13 |
rat |
| Andrew T Olagunju, Scott R Clark, Bernhard T Baun. Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome. The Australian and New Zealand journal of psychiatry. vol 53. issue 6. 2020-07-14. PMID:30957510. |
long-acting atypical antipsychotics in schizophrenia: a systematic review and meta-analyses of effects on functional outcome. |
2020-07-14 |
2023-08-13 |
Not clear |
| Sergio Linsambarth, Alvaro Jeria, Keren Avirame, Doron Todder, Raúl Riquelme, Jimmy Stehber. Deep Transcranial Magnetic Stimulation for the Treatment of Negative Symptoms in Schizophrenia: Beyond an Antidepressant Effect. The journal of ECT. vol 35. issue 4. 2020-06-15. PMID:31764455. |
negative symptoms of schizophrenia show limited response to both typical and atypical antipsychotics. |
2020-06-15 |
2023-08-13 |
Not clear |